Lyo-Updated

DRUG PRODUCT CGMP LYOPHILIZATION

Emergent’s 87,000 sq. ft. GMP manufacturing facility in Baltimore, Maryland has experience in producing over 40+ commercial products and more than 200 commercial candidates, and is designed to support the manufacture of the most critical and complex vaccines and therapeutics.

With flexible capacity equipped to handle single or multi-day filling campaigns, our experienced analytical and process tech transfer teams stand ready to rapidly onboard your program from project inception to manufacturing — with a steadfast commitment to quality and safety every step of the way. 

 

Turn-key lyophilization solutions:
  • 3 lyophilization units, with a total capacity of 530 sq. ft. 
  • Lyophilization cycle development studies from design, implementation, and associated material characterization (i.e., FTIR, DSC and Freeze-Dry Microscopy)
  • Elucidation and optimization of critical cycle parameters conducted within our integrated network will significantly reduce timelines and maximize the success of your lyophilized drug product 

Learn More About Emergent's Drug Product Services

 

IMA Lyo - 240 sq. ft. 

 

Hull Lyo - 216 sq. ft. 

 

Martin Christ Lyo - 74 sq. ft. 

Get Started

We welcome an opportunity to learn about your next project and explore how our team can support your needs.

Complete the form below and we will respond by phone or email quickly. 

If you need immediate assistance, you can contact us directly at +1 800-441-4225 (toll-free) or via cdmo@ebsi.com.